- Home
- THC vs ICLR Comparison
THC vs ICLR Comparison
Compare THC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THC
- ICLR
- Stock Information
- Founded
- THC 1967
- ICLR 1990
- Country
- THC United States
- ICLR Ireland
- Employees
- THC N/A
- ICLR N/A
- Industry
- THC Hospital/Nursing Management
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- THC Health Care
- ICLR Health Care
- Exchange
- THC Nasdaq
- ICLR Nasdaq
- Market Cap
- THC 15.7B
- ICLR 13.7B
- IPO Year
- THC N/A
- ICLR 1998
- Fundamental
- Price
- THC $192.71
- ICLR $175.00
- Analyst Decision
- THC Buy
- ICLR Buy
- Analyst Count
- THC 17
- ICLR 15
- Target Price
- THC $197.06
- ICLR $209.93
- AVG Volume (30 Days)
- THC 1.1M
- ICLR 1.0M
- Earning Date
- THC 10-28-2025
- ICLR 10-22-2025
- Dividend Yield
- THC N/A
- ICLR N/A
- EPS Growth
- THC N/A
- ICLR 13.11
- EPS
- THC 15.65
- ICLR 9.73
- Revenue
- THC $20,683,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- THC $3.29
- ICLR N/A
- Revenue Next Year
- THC $4.28
- ICLR $1.73
- P/E Ratio
- THC $12.32
- ICLR $17.98
- Revenue Growth
- THC N/A
- ICLR N/A
- 52 Week Low
- THC $109.82
- ICLR $125.10
- 52 Week High
- THC $199.99
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- THC 64.96
- ICLR 53.09
- Support Level
- THC $185.00
- ICLR $164.00
- Resistance Level
- THC $199.99
- ICLR $180.95
- Average True Range (ATR)
- THC 4.77
- ICLR 6.38
- MACD
- THC 0.41
- ICLR -0.99
- Stochastic Oscillator
- THC 65.27
- ICLR 64.59
About THC Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.